What is the projected market size of the Asia-Pacific EPA and DHA Market by 2031?

The Asia-Pacific EPA and DHA Market is projected to reach approximately 1.28 USD BIllion by 2031.

Which region is the largest market for the Asia-Pacific EPA and DHA Market?

China is the largest market for the Asia-Pacific EPA and DHA Market.

Which region is the fastest-growing market for the Asia-Pacific EPA and DHA Market?

India is the fastest-growing market for the Asia-Pacific EPA and DHA Market.

Which segment leads the By Product Type category of the Asia-Pacific EPA and DHA Market?

Docosahexaenoic Acid (DHA) leads the By Product Type category of the Asia-Pacific EPA and DHA Market, accounting for approximately 16% share.

New

Asia-Pacific EPA and DHA Market Outlook, 2031

2026

Asia-Pacific EPA and DHA Market Outlook, 2031

Asia-Pacific EPA & DHA Market is segmented into By Product Type (EPA, DHA); By Application (Dietary Supplements, Infant Formula, Pharmaceuticals, Food & Beverages, Clinical Nutrition & Medical Foods, Pet Nutrition); By Source (Fish Oil, Algal Oil, Krill Oil, Other Marine Sources).

Bonafide Research
30-10-2026
Pages : 95
Figures : 13
Tables : 27
Region : Asia-Pacific
Category : Food & Beverages
Food

Schedule a Call
Priyanka Makwana — Research Analyst

Buy Now Get Free sample

The Asia pacific EPA and DHA Market is expected to reach a market size of more than USD 1.28 Billion by 2031.

Historical Period2020-2024
Base Year2025
Forecast Period2026-2031
Market Size (2031) USD 1.28 BIllion
Largest Market China
Fastest Market India
Format

Featured Companies

1. Basf SE
2. Chambal Fertilisers
3. Archer-Daniels-Midland Company
4. Omega Protein Corporation
5. Croda International plc
6. Corbion N.V.
More...

Highend Report

Highend report of this product is available

View

New Report Guarantee

If you purchase this report now and we update it in next 100 days, get it free!

EPA and DHA Market Market Market Analysis

The Asia Pacific EPA & DHA Market has a distinct demand structure because the region combines large seafood-producing economies, established functional food markets, expanding nutraceutical manufacturing, and a growing consumer base for specialised nutrition. Unlike mature Western markets, demand is developing across different stages of the value chain. Japan and South Korea have established functional food and health supplement industries, China combines large-scale food manufacturing with significant seafood processing, and India and Southeast Asian countries are creating new opportunities through expanding nutraceutical consumption. This combination makes the region important not only as a consumer market but also as a production, processing, and distribution base for omega-3 ingredients. According to the research report, "Asia pacific EPA and DHA Market Outlook, 2031," published by Bonafide Research, the Asia pacific EPA and DHA Market is expected to reach a market size of more than USD 1.28 Billion by 2031.The regional seafood industry plays an important role in shaping the EPA and DHA supply chain. China, India, Vietnam, Thailand, and Japan have significant fisheries, aquaculture, and seafood-processing activities. These industries create opportunities for marine ingredient recovery from suitable fish-processing materials, although the availability of usable raw materials depends on species, processing methods, and oil quality. The development of refining, concentration, purification, and ingredient-processing capabilities is important for converting marine oils into ingredients suitable for human nutrition and specialised applications. Asia's dominant position in global aquaculture production also creates an important connection between marine ingredients and aquafeed manufacturing. Another distinctive feature is the coexistence of traditional nutritional products and modern omega-3 formulations. In Japan, functional food development and scientifically positioned health products support specialised omega-3 applications. In China, demand is influenced by infant nutrition, health-oriented food products, and a large domestic food manufacturing industry. India presents opportunities through the expansion of nutraceutical brands, pharmacy distribution, and online supplement sales. Across Southeast Asia, increasing urbanisation and changing food consumption habits are creating opportunities for fortified foods and nutritional supplements. This variety means that ingredient suppliers must adapt their product concentrations, delivery formats, pricing, and regulatory documentation to individual country requirements.

to Download this information in a PDF

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Market Dynamics

Market Drivers•  Expansion of Regional Nutraceutical Manufacturing: The development of domestic nutraceutical and supplement manufacturing in India, China, Japan, and South Korea is increasing opportunities for EPA and DHA ingredient suppliers. Local brands are introducing omega-3 capsules, softgels, liquid formulations, and specialised nutritional products. India's FSSAI framework specifically provides regulatory categories for health supplements and nutraceuticals, supporting a formal product-development and manufacturing environment.
•  Strong Aquaculture and Seafood Processing Base:  Asia Pacific's large aquaculture industry supports demand for marine-derived ingredients across aquafeed and related applications. China, Vietnam, India, and Thailand are important production and processing markets. The presence of seafood-processing operations creates opportunities for marine oil recovery, ingredient processing, and supply-chain development, although raw material suitability and availability differ by location.

Market Challenges•  Uneven Consumer Awareness and Purchasing Power: Demand for EPA and DHA products varies considerably across Asia Pacific. Consumers in developed markets may be familiar with specialised omega-3 supplements, while price sensitivity and limited product awareness can restrict adoption in developing markets. Manufacturers must balance ingredient concentration, product quality, and retail pricing to reach different consumer groups.
•  Raw Material and Processing Constraints:  Although Asia Pacific has extensive seafood production, this does not automatically ensure consistent supplies of high-quality EPA- and DHA-rich oils. Raw material composition varies by fish species, season, and processing method. Manufacturers must invest in appropriate extraction, refining, concentration, and oxidation-control processes to obtain ingredients suitable for specialised nutritional applications.

Market Trends•  Development of Regional Omega-3 Ingredient Processing:  Companies are increasingly focused on improving local marine oil processing, purification, and concentration capabilities. This creates opportunities to supply both domestic supplement manufacturers and international customers requiring specialised EPA and DHA ingredients.
•  Country-Specific Product Development:  Manufacturers are developing omega-3 products suited to local consumer preferences, including different capsule sizes, liquid formulations, combination supplements, and fortified food products. This approach allows brands to serve different price points and nutritional requirements across developed and emerging Asia Pacific markets.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Priyanka Makwana

Research Analyst

EPA and DHA Market Market Segmentation

By Product Type	Eicosapentaenoic Acid (EPA)
	Docosahexaenoic Acid (DHA)
By Application	Dietary Supplements
	Infant Formula
	Pharmaceuticals
	Food & Beverages
	Clinical Nutrition & Medical Foods
	Pet Nutrition
By Source	Fish Oil
	Algae Oil
	Krill Oil
	Other Marine Sources
Asia-Pacific	China
	Japan
	India
	Australia
	South Korea

EPA represents the fastest-growing product type segment in the Asia Pacific EPA & DHA Market, supported by increasing demand for specialised omega-3 formulations, expanding nutraceutical manufacturing, and growing interest in targeted nutritional products. Its applications in dietary supplements, cardiovascular nutrition, and pharmaceutical formulations are creating additional opportunities across the region. The growth of EPA is supported by the changing structure of the regional nutritional supplement industry, where manufacturers are moving beyond conventional fish oil products towards specialised formulations with specific fatty acid concentrations. Japan and South Korea have established markets for functional nutrition, while China and India are witnessing increasing development of health supplements and nutraceutical products. Manufacturers are introducing EPA-focused capsules, concentrated marine oils, liquid supplements, and combination formulations to address different consumer requirements. The expansion of online health platforms, pharmacy distribution, and domestic supplement brands is also improving the availability of specialised omega-3 products. In addition, growing interest in cardiovascular wellness and healthy ageing is encouraging consumers to explore targeted nutritional solutions. Ingredient suppliers are responding through improved concentration technologies, customised EPA-to-DHA ratios, and specialised formulations for supplement and pharmaceutical manufacturers. Pet Nutrition represents the fastest-growing application segment in the Asia Pacific EPA & DHA Market, supported by increasing pet ownership, expanding premium pet food consumption, and growing demand for functional animal nutrition products. The incorporation of omega-3 ingredients into specialised pet food, nutritional supplements, and functional treats is creating new opportunities for EPA and DHA suppliers. The growth of Pet Nutrition is closely connected to the expansion of organised pet care industries and changing consumer attitudes towards companion animal health. Japan and Australia have established premium pet food markets, while China and South Korea are experiencing increasing demand for specialised animal diets and functional pet products. India and Southeast Asian countries are also emerging as important opportunities as urban pet ownership, veterinary services, organised retail, and online pet food distribution continue to develop. Pet food manufacturers are incorporating EPA and DHA into dry food, wet food, fish oil supplements, functional treats, and veterinary diets to provide additional nutritional benefits. These ingredients are increasingly used in formulations targeting skin and coat condition, joint health, mobility, and overall animal wellbeing. Furthermore, manufacturers are developing products for different animal life stages, breed sizes, and nutritional requirements, creating demand for customised omega-3 ingredient compositions. The growing availability of premium imported and domestically manufactured pet food products is further supporting this application. These developments are expected to make Pet Nutrition the fastest-growing application segment in the Asia Pacific market. Algae Oil represents the fastest-growing source segment in the Asia Pacific EPA & DHA Market, supported by increasing interest in alternative omega-3 ingredients, growing demand for vegetarian nutritional products, and technological developments in microalgae cultivation and oil extraction. Its application in infant nutrition, dietary supplements, functional foods, and specialised nutritional formulations is creating new opportunities across the region. The growth of Algae Oil is supported by its ability to provide omega-3 fatty acids without depending directly on conventional fish-derived raw materials. This characteristic is particularly relevant for manufacturers targeting vegetarian consumers, specialised infant nutrition products, and customers seeking alternative ingredient sources. Japan, China, South Korea, and Australia offer opportunities through their established food technology, biotechnology, and functional nutrition industries, while India is developing opportunities through its expanding nutraceutical and alternative ingredient manufacturing sector. Algae-derived DHA is already relevant to specialised infant formula and nutritional products, while developments in cultivation, fermentation, extraction, and purification technologies are creating opportunities to improve commercial production capabilities. Ingredient manufacturers are also exploring algae-based oils for dietary supplements, fortified beverages, clinical nutrition, and selected animal nutrition applications. The growing focus on supply diversification is another important factor, as manufacturers seek alternatives that can complement conventional marine oil sourcing. However, production costs, cultivation efficiency, and the ability to achieve commercially competitive ingredient concentrations remain important considerations.

to Download this information in a PDF

EPA and DHA Market Market Market Regional Insights

China represents the largest country market in the Asia Pacific EPA & DHA Market, supported by its extensive seafood processing industry, large-scale nutritional product manufacturing, and established demand for specialised food and health ingredients. The country's strong presence across marine ingredient processing, infant nutrition, dietary supplements, and aquaculture creates a broad commercial base for EPA and DHA consumption. The growth of the EPA & DHA market in China is closely connected to its position as both a major seafood-producing economy and a large consumer market for nutritional products. The country's extensive fisheries and aquaculture activities support marine ingredient sourcing, while its developed food processing industry provides opportunities for fish oil extraction, refining, concentration, and further ingredient applications. Demand is also supported by the expansion of infant formula, maternal nutrition, and specialised food products containing DHA and other omega-3 ingredients. Domestic supplement manufacturers are developing capsules, softgels, liquid oils, and functional nutritional products to serve consumers increasingly interested in preventive healthcare and healthy ageing. In addition, China's large aquaculture and animal nutrition industries create industrial demand for marine-derived oils and specialised omega-3 ingredients. The presence of domestic ingredient processors and international suppliers also strengthens the availability of different EPA and DHA formulations. These factors, combined with China's manufacturing capabilities, established seafood supply chains, and expanding nutritional product industries, support its position as the largest country market in the Asia Pacific EPA & DHA Market.

to Download this information in a PDF

Don't pay for what you don't need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Companies Mentioned

Basf SE
Chambal Fertilisers
Archer-Daniels-Midland Company
Omega Protein Corporation
Croda International plc
Corbion N.V.
Nissui Corporation
DSM-Firmenich AG
Oracle Health
KinOmega Biopharm Inc.

1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.4. Supply chain Analysis
2.5. Policy & Regulatory Framework
2.6. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. Asia-Pacific EPA and DHA Market Outlook
6.1. Market Size By Value
6.2. Market Share By Country
6.3. Market Size and Forecast, By Product Type
6.4. Market Size and Forecast, By Application
6.5. Market Size and Forecast, By Source
6.6. China EPA and DHA Market Outlook
6.6.1. Market Size by Value
6.6.2. Market Size and Forecast By Product Type
6.6.3. Market Size and Forecast By Application
6.6.4. Market Size and Forecast By Source
6.7. Japan EPA and DHA Market Outlook
6.7.1. Market Size by Value
6.7.2. Market Size and Forecast By Product Type
6.7.3. Market Size and Forecast By Application
6.7.4. Market Size and Forecast By Source
6.8. India EPA and DHA Market Outlook
6.8.1. Market Size by Value
6.8.2. Market Size and Forecast By Product Type
6.8.3. Market Size and Forecast By Application
6.8.4. Market Size and Forecast By Source
6.9. Australia EPA and DHA Market Outlook
6.9.1. Market Size by Value
6.9.2. Market Size and Forecast By Product Type
6.9.3. Market Size and Forecast By Application
6.9.4. Market Size and Forecast By Source
6.10. South Korea EPA and DHA Market Outlook
6.10.1. Market Size by Value
6.10.2. Market Size and Forecast By Product Type
6.10.3. Market Size and Forecast By Application
6.10.4. Market Size and Forecast By Source
7. Competitive Landscape
7.1. Competitive Dashboard
7.2. Business Strategies Adopted by Key Players
7.3. Key Players Market Positioning Matrix
7.4. Porter's Five Forces
7.5. Company Profile
7.5.1. DSM-Firmenich AG
7.5.1.1. Company Snapshot
7.5.1.2. Company Overview
7.5.1.3. Financial Highlights
7.5.1.4. Geographic Insights
7.5.1.5. Business Segment & Performance
7.5.1.6. Product Portfolio
7.5.1.7. Key Executives
7.5.1.8. Strategic Moves & Developments
7.5.2. BASF SE
7.5.3. Croda International plc
7.5.4. KD Pharma Group
7.5.5. Corbion N.V.
7.5.6. Archer-Daniels-Midland Company
7.5.7. Omega Protein Corporation
7.5.8. Nissui Corporation
7.5.9. KinOmega Biopharm Inc.
7.5.10. Arjuna Natural Pvt. Ltd.
8. Strategic Recommendations
9. Annexure
9.1. FAQ`s
9.2. Notes
10. Disclaimer

Table 1: Influencing Factors for EPA and DHA Market, 2025
Table 2: Top 10 Counties Economic Snapshot 2024
Table 3: Economic Snapshot of Other Prominent Countries 2022
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5: Asia-Pacific EPA and DHA Market Size and Forecast, By Product Type (2025 to 2031F) (In USD Billion)
Table 6: Asia-Pacific EPA and DHA Market Size and Forecast, By Application (2025 to 2031F) (In USD Billion)
Table 7: Asia-Pacific EPA and DHA Market Size and Forecast, By Source (2025 to 2031F) (In USD Billion)
Table 8: China EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 9: China EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 10: China EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 11: Japan EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 12: Japan EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 13: Japan EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 14: India EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 15: India EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 16: India EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 17: Australia EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 18: Australia EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 19: Australia EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 20: South Korea EPA and DHA Market Size and Forecast By Product Type (2025 to 2031F) (In USD Billion)
Table 21: South Korea EPA and DHA Market Size and Forecast By Application (2025 to 2031F) (In USD Billion)
Table 22: South Korea EPA and DHA Market Size and Forecast By Source (2025 to 2031F) (In USD Billion)
Table 23: Competitive Dashboard of top 5 players, 2025

Figure 1: Asia-Pacific EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 2: Asia-Pacific EPA and DHA Market Share By Country (2025)
Figure 3: China EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 4: Japan EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 5: India EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 6: Australia EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 7: South Korea EPA and DHA Market Size By Value (2025, 2025 & 2031F) (in USD Billion)
Figure 8: Porter's Five Forces of Global EPA and DHA Market

EPA and DHA Market Market Market Research FAQs

The Asia Pacific EPA & DHA Market is supported by the region's extensive seafood processing industry, expanding nutraceutical manufacturing, and growing demand for specialised nutritional products. Increasing applications in infant nutrition, dietary supplements, functional foods, aquaculture feed, and pet nutrition are creating opportunities for ingredient manufacturers across the region.

EPA is expected to be the fastest-growing product type due to increasing demand for specialised omega-3 formulations, cardiovascular nutrition products, and concentrated fatty acid supplements. The expansion of domestic nutraceutical brands and growing consumer interest in targeted nutritional solutions are further supporting demand across regional markets.

Algae Oil is gaining importance as a source of EPA and DHA due to increasing interest in alternative omega-3 ingredients, vegetarian nutritional products, and supply diversification. Improvements in microalgae cultivation, fermentation, and oil extraction technologies are creating opportunities for its use in infant nutrition, dietary supplements, functional foods, and specialised nutritional formulations.

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted